Many Unused Covid-19 Vaccines Could Result in Rp525 Billion Loss for Bio Farma

1
Nabilah Muhamad 06/12/2023 18:45 WIB
Image Loader
Memuat...

The Indonesian Supreme Audit Agency (BPK) found that problems in the Gotong Royong Vaccination Program (VGR) potentially burdened PT Bio Farma's finances by up to Rp525.17 billion.

Sales Target for Gotong Royong Vaccines and Undistributed Vaccines (2023)
  • A Font Kecil
  • A Font Sedang
  • A Font Besar
databoks

Access single data

Many Unused Covid-19 Vaccines Could Result in Rp525 Billion Loss for Bio Farma

Want to get more access to Data Stories with a more affordable price? Subscribe.

By subscribing, you join us in presenting quality data.

Get:

  • Premium Data Stories access
  • Comfortable reading without ads
  • Download data in XLS, PDF, and image format
  • Access to data source information
See more
Basic
Rp100.000
Rp50.000/month
Professional
Rp100.000
Rp150.000/month
Institutional For organizations

We accept the following payments:

Qris OVO DANA ShopeePay AstraPay LinkAja
BCA Master Card Visa JCB
Qris OVO DANA ShopeePay AstraPay LinkAja BCA Master Card Visa JCB
Some payment methods are still in the process of being activated.

Popular Data

Loading...